Ketamine Therapy Shows Potential In Treatment Of Alcohol Use Disorder, New Study Finds
Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) published encouraging data from a Phase II trial looking at ketamine-assisted therapy for the treatment of alcohol use disorder.
